US Physical Therapy financials
$86.15+0.07%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M | $423.0M | $482.0M | $453.9M | $414.1M | $356.5M |
| Gross profit | $781.0M | $671.3M | $604.8M | $553.1M | $216.6M | $187.3M | $207.7M | $194.7M | $177.0M | $158.1M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 43.7% | 44.3% | 43.1% | 42.9% | 42.7% | 44.3% |
| Operating income | $86.7M | $63.0M | $50.5M | $56.8M | $68.0M | $52.4M | $67.4M | $60.3M | $54.7M | $49.5M |
| Net income | $21.6M | $27.7M | $18.1M | $29.3M | $31.1M | $31.8M | $31.3M | $16.6M | $22.1M | $20.6M |
| Net margin | 2.8% | 4.1% | 3.0% | 5.3% | 6.3% | 7.5% | 6.5% | 3.7% | 5.3% | 5.8% |
| Diluted EPS | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 | $2.45 | $1.31 | $1.76 | $1.64 |
| EBITDA | $109.1M | $84.1M | $83.7M | $80.7M | $82.2M | $62.9M | $77.5M | $70.1M | $65.0M | $58.4M |
| Operating cash flow | $75.1M | $74.9M | $82.0M | $58.5M | $76.4M | $100.0M | $62.4M | $73.0M | $56.5M | $51.0M |
| Free cash flow | $61.0M | $65.8M | $72.7M | $50.3M | $68.2M | $92.4M | $52.3M | $65.8M | $49.4M | $42.8M |
| Diluted shares | 15.2M | 15.1M | 14.2M | 13.0M | 12.9M | 12.8M | 12.8M | 12.7M | 12.6M | 12.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.6M | $41.4M | $152.8M | $31.6M | $28.6M | $32.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $162.5M | $153.5M | $146.7M | $183.7M | $118.4M | $21.5M |
| Total assets | $1.20B | $1.17B | $997.2M | $858.2M | $749.4M | $594.4M |
| Total liabilities | $433.8M | $408.4M | $345.0M | $373.6M | $297.0M | $184.4M |
| Shareholders' equity | $476.9M | $490.0M | $477.4M | $317.1M | $297.2M | $277.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology